BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15696974)

  • 1. Chromosomal and genetic aberrations differ with meningioma subtype.
    Wada K; Maruno M; Suzuki T; Kagawa N; Hashiba T; Fujimoto Y; Hashimoto N; Izumoto S; Yoshimine T
    Brain Tumor Pathol; 2004; 21(3):127-33. PubMed ID: 15696974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal and genetic abnormalities in benign and malignant meningiomas using DNA microarray.
    Wada K; Maruno M; Suzuki T; Kagawa N; Hashiba T; Fujimoto Y; Hashimoto N; Izumoto S; Yoshimine T
    Neurol Res; 2005 Oct; 27(7):747-54. PubMed ID: 16197812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue.
    Pfisterer WK; Coons SW; Aboul-Enein F; Hendricks WP; Scheck AC; Preul MC
    J Neurooncol; 2008 Mar; 87(1):43-50. PubMed ID: 18060363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic and proliferative potentials in meningiomas.
    Debiec-Rychter M; Biernat W; Limon J; Kordek R; Izycka E; Borowska-Lehman J; Imieliński B; Liberski PP
    Pol J Pathol; 1999; 50(4):243-8. PubMed ID: 10721264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].
    Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
    Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
    BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High resolution genomic profiling and classical cytogenetics in a group of benign and atypical meningiomas.
    Holland H; Mocker K; Ahnert P; Kirsten H; Hantmann H; Koschny R; Bauer M; Schober R; Scholz M; Meixensberger J; Krupp W
    Cancer Genet; 2011 Oct; 204(10):541-9. PubMed ID: 22137484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome 14 copy number abnormalities in meningiomas.
    Espinosa AB; Mackintosh C; Maíllo A; Gutierrez L; Sousa P; Merino M; Ortiz J; de Alava E; Orfao A; Tabernero MD
    Eur J Hum Genet; 2008 Dec; 16(12):1450-8. PubMed ID: 18628790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple meningioma with different grades of malignancy: case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogenetics.
    Mocker K; Holland H; Ahnert P; Schober R; Bauer M; Kirsten H; Koschny R; Meixensberger J; Krupp W
    Pathol Res Pract; 2011 Jan; 207(1):67-72. PubMed ID: 20926204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.
    Weber RG; Boström J; Wolter M; Baudis M; Collins VP; Reifenberger G; Lichter P
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14719-24. PubMed ID: 9405679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Whole Chromosomal Gains Define Angiomatous Meningiomas and Are Absent From the Tumor Vasculature.
    Ahrendsen JT; Hsu N; Wolf Z; Bryke C; Varma H
    J Neuropathol Exp Neurol; 2020 Jun; 79(6):618-625. PubMed ID: 32357369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal losses and gains in meningiomas: comparative genomic hybridization (CGH) study of the whole genome.
    Maruno M; Yoshimine T; Muhammad AK; Ninomiya H; Hayakawa T
    Neurol Res; 1998 Oct; 20(7):612-6. PubMed ID: 9785589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
    Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
    Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome-specific probes.
    Sayagués JM; Tabernero MD; Maillo A; Díaz P; Rasillo A; Bortoluci A; Gomez-Moreta J; Santos-Briz A; Morales F; Orfao A
    Cytometry; 2002 Jun; 50(3):153-9. PubMed ID: 12116338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.
    Buckley PG; Jarbo C; Menzel U; Mathiesen T; Scott C; Gregory SG; Langford CF; Dumanski JP
    Cancer Res; 2005 Apr; 65(7):2653-61. PubMed ID: 15805262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
    Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of chromosome 22 loci in meningioma. Alterations in the leukemia inhibitory factor (LIF) locus.
    Pergolizzi RG; Erster SH
    Mol Chem Neuropathol; 1994; 21(2-3):189-217. PubMed ID: 7916188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic landscape of meningiomas.
    Lee Y; Liu J; Patel S; Cloughesy T; Lai A; Farooqi H; Seligson D; Dong J; Liau L; Becker D; Mischel P; Shams S; Nelson S
    Brain Pathol; 2010 Jul; 20(4):751-62. PubMed ID: 20015288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.